- Previous Close
55.00 - Open
55.00 - Bid 51.20 x --
- Ask 59.99 x --
- Day's Range
55.00 - 55.00 - 52 Week Range
50.00 - 80.00 - Volume
1,000 - Avg. Volume
13,363 - Market Cap (intraday)
414.978M - Beta (5Y Monthly) -0.63
- PE Ratio (TTM)
26.19 - EPS (TTM)
2.10 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, neurology, etc. The company also promotes and markets specialty chemicals; and active pharmaceuticals ingredients and its intermediates. It also exports its products. The company was founded in 1944 and is headquartered in Mumbai, India.
www.cbcpharma.com37
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: CBPL.BO
View MorePerformance Overview: CBPL.BO
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CBPL.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CBPL.BO
View MoreValuation Measures
Market Cap
414.98M
Enterprise Value
612.76M
Trailing P/E
26.19
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.25
Price/Book (mrq)
1.40
Enterprise Value/Revenue
0.37
Enterprise Value/EBITDA
14.66
Financial Highlights
Profitability and Income Statement
Profit Margin
0.94%
Return on Assets (ttm)
2.47%
Return on Equity (ttm)
5.47%
Revenue (ttm)
1.68B
Net Income Avi to Common (ttm)
15.8M
Diluted EPS (ttm)
2.10
Balance Sheet and Cash Flow
Total Cash (mrq)
29.25M
Total Debt/Equity (mrq)
76.46%
Levered Free Cash Flow (ttm)
-15.43M